Literature DB >> 16288740

The PCNA-associated factor KIAA0101/p15(PAF) binds the potential tumor suppressor product p33ING1b.

Fiona Simpson1, Kelly Lammerts van Bueren, Natalie Butterfield, Jennifer S Bennetts, Josephine Bowles, Christelle Adolphe, Lisa A Simms, Joanne Young, Michael D Walsh, Barbara Leggett, Lindsay F Fowles, Carol Wicking.   

Abstract

The KIAA0101/p15(PAF)/OEATC-1 protein was initially isolated in a yeast two-hybrid screen for proliferating cell nuclear antigen (PCNA) binding partners, and was shown to bind PCNA competitively with the cell cycle regulator p21(WAF). PCNA is involved in DNA replication and damage repair. Using polyclonal antisera raised against a p15(PAF) fusion protein, we have shown that in a range of mammalian tumor and non-tumor cell lines the endogenous p15(PAF) protein localises to the nucleus and the mitochondria. Under normal conditions no co-localisation with PCNA could be detected, however following exposure to UV it was possible to co-immunoprecipitate p15(PAF) and PCNA from a number of cell lines, suggesting a UV-enhanced association of the two proteins. Overexpression of p15(PAF) in mammalian cells was also found to protect cells from UV-induced cell death. Based on similarities between the behaviour of p15(PAF) and the potential tumor suppressor product p33ING1b, we have further shown that these two proteins interact in the same complex in cell cultures. This suggests that p15(PAF) forms part of a larger protein complex potentially involved in the regulation of DNA repair, apoptosis and cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288740     DOI: 10.1016/j.yexcr.2005.09.020

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  24 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

2.  KIAA0101 mRNA overexpression in peripheral blood mononuclear cells acts as predictive marker for hepatic cancer.

Authors:  Xiaomei Su; Tao Zhang; Peng Cheng; Yajie Zhu; Hua Li; Dong Li; Zhen Liu; Hui Gao; Zhenguo Zhao; Yu Zhao; Huanyi Liu
Journal:  Tumour Biol       Date:  2013-11-07

3.  KIAA0101 interacts with BRCA1 and regulates centrosome number.

Authors:  Zeina Kais; Sanford H Barsky; Haritha Mathsyaraja; Alicia Zha; Derek J R Ransburgh; Gang He; Robert T Pilarski; Charles L Shapiro; Kun Huang; Jeffrey D Parvin
Journal:  Mol Cancer Res       Date:  2011-06-14       Impact factor: 5.852

Review 4.  ING1 and ING2: multifaceted tumor suppressor genes.

Authors:  Claire Guérillon; Delphine Larrieu; Rémy Pedeux
Journal:  Cell Mol Life Sci       Date:  2013-02-15       Impact factor: 9.261

5.  NS5ATP9 mRNA levels in peripheral blood mononuclear cells predict prognosis in patients with gastric cancer.

Authors:  Dawei Yuan; Kun Zhu; Chengxue Dang; Yuewen Zheng; Rong Yan; Lei Shi; Kang Li
Journal:  Med Oncol       Date:  2014-07-05       Impact factor: 3.064

Review 6.  Reviewing the current classification of inhibitor of growth family proteins.

Authors:  Motoko Unoki; Kensuke Kumamoto; Seiichi Takenoshita; Curtis C Harris
Journal:  Cancer Sci       Date:  2009-04-28       Impact factor: 6.716

7.  NS5ATP9 suppresses activation of human hepatic stellate cells, possibly via inhibition of Smad3/phosphorylated-Smad3 expression.

Authors:  Mengran Zhang; Jinqian Zhang; Shunai Liu; Qi Wang; Guoxian Lin; Rongxian Qiu; Min Quan; Jun Cheng
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

8.  NS5ATP9 contributes to inhibition of cell proliferation by hepatitis C virus (HCV) nonstructural protein 5A (NS5A) via MEK/extracellular signal regulated kinase (ERK) pathway.

Authors:  Qi Wang; Yongsheng Wang; Yue Li; Xuesong Gao; Shunai Liu; Jun Cheng
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

9.  Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.

Authors:  Emman Shubbar; Anikó Kovács; Shahin Hajizadeh; Toshima Z Parris; Szilárd Nemes; Katrin Gunnarsdóttir; Zakaria Einbeigi; Per Karlsson; Khalil Helou
Journal:  BMC Cancer       Date:  2013-01-02       Impact factor: 4.430

10.  p15(PAF) is an Rb/E2F-regulated S-phase protein essential for DNA synthesis and cell cycle progression.

Authors:  Chih-Ning Chang; Mow-Jung Feng; Yu-Ling Chen; Ray-Hwang Yuan; Yung-Ming Jeng
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.